The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 patients: A systematic review and meta-analysis
Leila Nikniaz, Mohammad Amin Akbarzadeh, Hossein Hosseinifard, Mohammad-Salar Hosseini
Pharmaceutical Sciences, doi:10.34172/ps.2021.13
Background: Several studies have suggested the positive impact of vitamin D on patients infected with SARS-CoV-2. This systematic review aims to evaluate the effects of vitamin D supplementation on clinical outcomes and mortality rate of COVID-19 patients. Methods: A comprehensive search was conducted through the databases of PubMed, Scopus, Web of Knowledge, Embase, Ovid, and The Cochrane Library without time and language limitation, until December 16, 2020. The results were screened, and the outcomes of interest were extracted. Using the Joanna Briggs Institute (JBI) Critical Appraisal Tools, the remaining results were appraised critically. Statistical analysis was performed using the Comprehensive Meta-Analysis (CMA) software version 2.0. Results: Of the 2311 results, four studies and 259 patients were enrolled, including 139 patients in vitamin D intervention groups. The pooled analysis of three studies, reporting the patients' survival and mortality rate, showed a significantly lower mortality rate among the intervention groups compared with the control groups (OR=0.264, 95% CI=0.099-0.708, p-value=0.008). Two of the studies reported the clinical outcomes based on the World Health Organization's Ordinal Scale for Clinical Improvement (OSCI) score for COVID-19, where both of them showed a significant decrease in OSCI score in the vitamin D intervention groups. One study reported a lower rate of intensive care unit (ICU) admission, and one study reported a significant decrease in serum levels of Fibrinogen. Conclusion: Prescribing vitamin D supplementation to patients with COVID-19 infection seems to decrease the mortality rate, the severity of the disease, and serum levels of the inflammatory markers. Further studies are needed to determine the ideal type, dosage, and duration of supplementation.
Author Contributions MAA and MSH contributed to the conceptualization and study design, LN and MSH defined the search strategy and performed the search through the databases, LN and MAA screened the results, LN and MSH critically assessed the studies, HH and MSH performed the analyses. MAA and MSH contributed to preparing the original draft of the manuscript, and LN and HH critically revised the manuscript.
Conflict of Interest The authors declare no competing interests regarding the submission and publication of this manuscript.
Supplementary Data Supplementary data are available on the journal's web site along with the published article.
References
Akbari, Tabrizi, Lankarani, Aria, Vakili et al., The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis, Life Sci,
doi:10.1016/j.lfs.2020.118167Alvarez, Aguilar-Jimenez, Rugeles, The potential protective role of vitamin D supplementation on HIV-1 infection, Front Immunol,
doi:10.3389/fimmu.2019.02291Annweiler, Corvaisier, Gautier, Dubée, Legrand et al., Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: The GERIA-COVID quasiexperimental study, Nutrients
Annweiler, Hanotte, De L'eprevier, Sabatier, Lafaie et al., Vitamin D and survival in COVID-19 patients: A quasi-experimental study, J Steroid Biochem Mol Biol,
doi:10.1016/j.jsbmb.2020.105771Aziz, Fatima, Assaly, Elevated interleukin-6 and severe COVID-19: A meta-analysis, J Med Virol,
doi:10.1002/jmv.25948Azrielant, Shoenfeld, Vitamin D and the immune system, Isr Med Assoc J
Belderbos, Houben, Wilbrink, Lentjes, Bloemen et al., Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis, Pediatrics,
doi:10.1542/peds.2010-3054Brenner, Holleczek, Schöttker, Vitamin D insufficiency and deficiency and mortality from respiratory diseases in a cohort of older adults: potential for limiting the death toll during and beyond the COVID-19 pandemic?, Nutrients,
doi:10.3390/nu12082488Brockman-Schneider, Pickles, Gern, Effects of vitamin D on airway epithelial cell morphology and rhinovirus replication, PLoS One,
doi:10.1371/journal.pone.0086755Carpagnano, Lecce, Quaranta, Zito, Buonamico et al., Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest,
doi:10.1007/s40618-020-01370-xCastillo, Costa, Barrios, Díaz, Miranda et al., Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Steroid Biochem Mol Biol,
doi:10.1016/j.jsbmb.2020.105751Charan, Goyal, Saxena, Yadav, Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis, J Pharmacol Pharmacother,
doi:10.4103/0976-500X.103685Daniel, Sartory, Zahn, Radeke, Stein, Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile, J Pharmacol Exp Ther,
doi:10.1124/jpet.107.127209Deluccia, Clegg, Sukumar, The implications of vitamin D deficiency on COVID-19 for atrisk populations, Nutr Rev,
doi:10.1093/nutrit/nuaa092Fiorino, Gallo, Zippi, Sabbatani, Manfredi et al., Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy, Aging Clin Exp Res,
doi:10.1007/s40520-020-01669-yGreiller, Martineau, Modulation of the immune response to respiratory viruses by vitamin D, Nutrients,
doi:10.3390/nu7064240Harris, Carson, Baillie, Horby, Nair, An evidence-based framework for priority clinical research questions for COVID-19, J Glob Health,
doi:10.7189/jogh.10-011001Laird, Rhodes, Kenny, Vitamin D and inflammation: potential implications for severity of covid-19, Ir Med J
Leal, Lima, De Aquino, De Sousa, Gadelha et al., Vitamin D (VD3) antioxidative and anti-inflammatory activities: Peripheral and central effects, Eur J Pharmacol,
doi:10.1016/j.ejphar.2020.173099Lips, Cashman, Lamberg-Allardt, Bischoff-Ferrari, Obermayer-Pietsch et al., Current vitamin D status in European and S12 | Pharmaceutical Sciences, 2021, 27(Suppl 1), S1-S12 Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society, Eur J Endocrinol,
doi:10.1530/EJE-18-0736Liu, Long, Xiong, Chen, Ma et al., Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID-19: a rapid systematic review and meta-analysis, Clin Cardiol,
doi:10.1002/clc.23421Liu, Sun, Wang, Zhang, Zhao et al., Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and metaanalysis, Int J Infect Dis,
doi:10.1016/j.ijid.2020.12.077Loeb, Dang, Thiem, Thanabalan, Wang et al., Effect of Vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: A randomized controlled trial, Influenza Other Respir Viruses,
doi:10.1111/irv.12615Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ,
doi:10.1136/bmj.i6583Mccartney, Byrne, Optimisation of vitamin D status for enhanced Immuno-protection against covid-19, Ir Med J
Mohamed, Almonaem, Mansour, Algebaly, Khattab et al., Importance of studying the levels of hepcidin and vitamin D in Egyptian children with chronic hepatitis C, J Transl Int Med,
doi:10.2478/jtim-2019-0004Moher, Liberati, Tetzlaff, Altman, Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med,
doi:10.1371/journal.pmed.1000097Pang, Cardosa, Guzman, Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS), Immunol Cell Biol,
doi:10.1038/sj.icb.7100008Pereira, Damascena, Azevedo, De Almeida Oliveira, Da et al., Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis, Crit Rev Food Sci Nutr,
doi:10.1080/10408398.2020.1841090Potempa, Rajab, Hart, Bordon, Fernandez-Botran, Insights into the use of C-reactive protein as a diagnostic index of disease severity in COVID-19 infections, Am J Trop Med Hyg,
doi:10.4269/ajtmh.20-0473Rastogi, Bhansali, Khare, Suri, Yaddanapudi et al., Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study), Postgrad Med J,
doi:10.1136/postgradmedj-2020-139065Rhodes, Dunstan, Laird, Subramanian, Kenny, COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D, BMJ Nutr Prev Health,
doi:10.1136/bmjnph-2020-000110Rhodes, Subramanian, Laird, Griffin, Kenny, Perspective: Vitamin D deficiency and COVID-19 severity-plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis (R1), J Intern Med,
doi:10.1111/joim.13149Shojaeefar, Malih, Rezaei, The possible doubleedged sword effects of vitamin D on COVID-19: A hypothesis, Cell Biol Int,
doi:10.1002/cbin.11469Spinelli, Pellino, COVID-19 pandemic: perspectives on an unfolding crisis, Br J Surg,
doi:10.1002/bjs.11627Urashima, Segawa, Okazaki, Kurihara, Wada et al., Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren, Am J Clin Nutr,
doi:10.3945/ajcn.2009.29094Vanherwegen, Gysemans, Mathieu, Regulation of immune function by vitamin D and its use in diseases of immunity, Endocrinol Metab Clin,
doi:10.1016/j.ecl.2017.07.010Viard, Souberbielle, Kirk, Reekie, Knysz et al., Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study, Aids,
doi:10.1097/QAD.0b013e328347f6f7Wei, Christakos, Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D, Nutrients,
doi:10.3390/nu7105392Who, World Health Organization Coronavirus disease (COVID
{ 'indexed': {'date-parts': [[2022, 4, 2]], 'date-time': '2022-04-02T14:15:01Z', 'timestamp': 1648908901940},
'reference-count': 0,
'publisher': 'Maad Rayan Publishing Company',
'content-domain': {'domain': ['ps.tbzmed.ac.ir'], 'crossmark-restriction': False},
'short-container-title': ['Pharm Sci'],
'published-print': {'date-parts': [[2021, 3, 9]]},
'abstract': '<jats:p>Background: Several studies have suggested the positive impact of vitamin D on '
'patients infected with SARS-CoV-2. This systematic review aims to evaluate the effects of '
'vitamin D supplementation on clinical outcomes and mortality rate of COVID-19 patients. '
'Methods: A comprehensive search was conducted through the databases of PubMed, Scopus, Web of '
'Knowledge, Embase, Ovid, and The Cochrane Library without time and language limitation, until '
'December 16, 2020. The results were screened, and the outcomes of interest were extracted. '
'Using the Joanna Briggs Institute (JBI) Critical Appraisal Tools, the remaining results were '
'appraised critically. Statistical analysis was performed using the Comprehensive '
'Meta-Analysis (CMA) software version 2.0. Results: Of the 2311 results, four studies and 259 '
'patients were enrolled, including 139 patients in vitamin D intervention groups. The pooled '
'analysis of three studies, reporting the patients’ survival and mortality rate, showed a '
'significantly lower mortality rate among the intervention groups compared with the control '
'groups (OR=0.264, 95% CI=0.099–0.708, p-value=0.008). Two of the studies reported the '
'clinical outcomes based on the World Health Organization’s Ordinal Scale for Clinical '
'Improvement (OSCI) score for COVID-19, where both of them showed a significant decrease in '
'OSCI score in the vitamin D intervention groups. One study reported a lower rate of intensive '
'care unit (ICU) admission, and one study reported a significant decrease in serum levels of '
'Fibrinogen. Conclusion: Prescribing vitamin D supplementation to patients with COVID-19 '
'infection seems to decrease the mortality rate, the severity of the disease, and serum levels '
'of the inflammatory markers. Further studies are needed to determine the ideal type, dosage, '
'and duration of supplementation. </jats:p>',
'DOI': '10.34172/ps.2021.13',
'type': 'journal-article',
'created': {'date-parts': [[2021, 9, 30]], 'date-time': '2021-09-30T10:24:48Z', 'timestamp': 1632997488000},
'update-policy': 'http://dx.doi.org/10.34172/crossmark_policy',
'source': 'Crossref',
'is-referenced-by-count': 2,
'title': [ 'The impact of vitamin D supplementation on mortality rate and clinical outcomes of COVID-19 '
'patients: A systematic review and meta-analysis'],
'prefix': '10.34172',
'author': [ { 'ORCID': 'http://orcid.org/0000-0003-2951-936X',
'authenticated-orcid': True,
'given': 'Leila',
'family': 'Nikniaz',
'sequence': 'first',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-9589-104X',
'authenticated-orcid': True,
'given': 'Mohammad Amin',
'family': 'Akbarzadeh',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-1308-1244',
'authenticated-orcid': True,
'given': 'Hossein',
'family': 'Hosseinifard',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-2765-5018',
'authenticated-orcid': True,
'given': 'Mohammad-Salar',
'family': 'Hosseini',
'sequence': 'additional',
'affiliation': []}],
'member': '20123',
'published-online': {'date-parts': [[2021, 3, 9]]},
'container-title': ['Pharmaceutical Sciences'],
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://ps.tbzmed.ac.ir/Inpress/ps-34133.pdf',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://ps.tbzmed.ac.ir/Inpress/ps-34133.pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2021, 9, 30]],
'date-time': '2021-09-30T10:24:48Z',
'timestamp': 1632997488000},
'score': 1,
'resource': {'primary': {'URL': 'https://ps.tbzmed.ac.ir/Inpress/ps-34133'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 3, 9]]},
'references-count': 0,
'URL': 'http://dx.doi.org/10.34172/ps.2021.13',
'relation': {},
'ISSN': ['1735-403X', '2383-2886'],
'issn-type': [{'value': '1735-403X', 'type': 'print'}, {'value': '2383-2886', 'type': 'electronic'}],
'subject': ['General Pharmacology, Toxicology and Pharmaceutics', 'Pharmaceutical Science'],
'published': {'date-parts': [[2021, 3, 9]]},
'assertion': [ { 'value': 'Tabriz University of Medical Sciences',
'name': 'journal_owner',
'label': 'Journal Owner'},
{ 'value': 'Tabriz University of Medical Sciences',
'name': 'journal_publisher',
'label': 'Journal Publisher'},
{ 'value': '2021-01-26',
'order': 1,
'name': 'received',
'label': 'Received',
'group': {'name': 'publication_history', 'label': 'Publication History'}},
{ 'value': '2021-03-09',
'order': 2,
'name': 'accepted',
'label': 'Accepted',
'group': {'name': 'publication_history', 'label': 'Publication History'}},
{ 'value': '2021-03-09',
'order': 3,
'name': 'published',
'label': 'Published',
'group': {'name': 'publication_history', 'label': 'Publication History'}}]}
